The Combination of Serenoa Repens, Selenium and Lycopene is More Effective Than Serenoa Repens Alone to Prevent Hormone Dependent Prostatic Growth

被引:28
作者
Altavilla, Domenica [2 ]
Bitto, Alessandra [2 ]
Polito, Francesca [3 ]
Irrera, Natasha [2 ]
Marini, Herbert [3 ]
Arena, Salvatore [4 ]
Favilla, Vincenzo
Squadrito, Francesco [2 ]
Morgia, Giuseppe [1 ]
Minutoli, Letteria [2 ]
机构
[1] Univ Catania, Sch Med, Dept Urol, Polyclin Hosp, Catania, Italy
[2] Univ Messina, Dept Clin & Expt Med & Pharmacol, Pharmacol Sect, Messina, Italy
[3] Univ Messina, Sect Physiol & Human Nutr, Dept Biochem Physiol & Nutr Sci, Messina, Italy
[4] Univ Messina, Dept Urol, Messina, Italy
关键词
prostate; prostatic hyperplasia; Serenoa; lycopene; selenium; URINARY-TRACT SYMPTOMS; CELL-GROWTH; CANCER; HYPERPLASIA; EXPRESSION; PATHWAY; PROGRESSION; BCL-2;
D O I
10.1016/j.juro.2011.05.049
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Serenoa repens is frequently combined with other natural compounds, such as the carotenoid lycopene and the essential trace element Se, to increase its therapeutic activity in benign prostatic hyperplasia. We noted that the lycopene-Se-Serenoa repens combination has greater, enhanced anti-inflammatory activity, which might be of particular interest for benign prostatic hyperplasia treatment. Testosterone administration in rats is a suitable tool for investigating hormone dependent benign prostatic hyperplasia. We performed a comparison experiment between Serenoa repens and the lycopene-Se-Serenoa repens combination on prostate growth induced in rats by testosterone administration. Materials and Methods: Rats were treated daily with testosterone propionate (3 mg/kg subcutaneously) or its vehicle for 14 days. Testosterone administered animals were randomized to receive vehicle, Serenoa repens (25 mg/kg subcutaneously) or the combination of lycopene (3 mg/kg subcutaneously), Se (3 mg/kg subcutaneously) and Serenoa repens for 14 days. The rats were sacrificed and the prostate was removed for analysis. Results: Lycopene-Se-Serenoa repens was more effective than Serenoa repens alone for decreasing prostate weight and hyperplasia, augmenting pro-apoptotic Bax and caspase-9, and blunting anti-apoptotic Bcl-2 mRNA. Lycopene-Se-Serenoa repens also markedly decreased epidermal growth factor and vascular endothelial growth factor expression. Conclusions: The data indicate that the lycopene-Se-Serenoa repens combination is superior to Serenoa repens alone for decreasing hormone dependent prostatic growth.
引用
收藏
页码:1524 / 1529
页数:6
相关论文
共 31 条
  • [1] Arruzazabala ML, 2004, DRUG EXP CLIN RES, V30, P227
  • [2] Effect of Serenoa repens, Lyocopene, and Selenium on Proinflammatory IκB-α Phenotype Activation: An In Vitro And In Vivo Comparison Study
    Bonvissuto, Giulio
    Minutoli, Letteria
    Morgia, Giuseppe
    Bitto, Alessandra
    Polito, Francesca
    Irrera, Natasha
    Marini, Herbert
    Squadrito, Francesco
    Altavilla, Domenica
    [J]. UROLOGY, 2011, 77 (01) : 248.e9 - 248.e16
  • [3] Dissecting the pathways to death
    Daniel, PT
    [J]. LEUKEMIA, 2000, 14 (12) : 2035 - 2044
  • [4] Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438
  • [5] Di Silverio F, 1998, PROSTATE, V37, P77, DOI 10.1002/(SICI)1097-0045(19981001)37:2<77::AID-PROS3>3.0.CO
  • [6] 2-I
  • [7] Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation
    Gerstenbluth, RE
    Seftel, AD
    MacLennan, GT
    Rao, RN
    Corty, EW
    Ferguson, K
    Resnick, MI
    [J]. JOURNAL OF UROLOGY, 2002, 167 (05) : 2267 - 2270
  • [8] Mitochondria and apoptosis
    Green, DR
    Reed, JC
    [J]. SCIENCE, 1998, 281 (5381) : 1309 - 1312
  • [9] Evolution of the androgen receptor pathway during progression of prostate cancer
    Hendriksen, Peter J. M.
    Dits, Natasja F. J.
    Kokame, Koichi
    Veldhoven, Antoine
    van Weerden, Wytske M.
    Bangma, Chris H.
    Trapman, Jan
    Jenster, Guido
    [J]. CANCER RESEARCH, 2006, 66 (10) : 5012 - 5020
  • [10] BCL-2 FUNCTIONS IN AN ANTIOXIDANT PATHWAY TO PREVENT APOPTOSIS
    HOCKENBERY, DM
    OLTVAI, ZN
    YIN, XM
    MILLIMAN, CL
    KORSMEYER, SJ
    [J]. CELL, 1993, 75 (02) : 241 - 251